In addition to these tracers, [68Ga]Ga-pentixafor, a radiopharmaceutical targeting the C-X-C chemokine receptor type 4 (CXCR4), has emerged as a promising tool for imaging inflammatory and ischemic processes in cardiovascular diseases. Here, CXCR4 is linked to cardiovascular disorder.